Nasopharyngeal carcinoma
![Picture](/uploads/2/6/8/2/2682607/904986.jpg)
Nasopharyngeal carcinoma is a malignant and difficult to access cancer of the nasopharynx. We have treated stage III and IV of nasopharyngeal carcinoma with irradiation and local IL-2 therapy. Five years disease-free survival after irradiation only was 8%, whereas after the combination irradiation local-IL-2 therapy, it was 63%.